Wyden, Senate Democrats, Press Pharmaceutical Companies for Evidence of Cost Savings for Americans Following Secret Deals With Trump
March 07, 2026
March 07, 2026
WASHINGTON, March 7 -- Sen. Ron Wyden, D-Oregon, ranking member of the Senate Finance Committee, issued the following news release:
* * *
Wyden, Senate Democrats, Press Pharmaceutical Companies for Evidence of Cost Savings for Americans Following Secret Deals with Trump
Senate Democrats Continue Probe Into Trump's Sweetheart Deals for Big Pharma, Seeking Evidence That American Taxpayers Will Benefit from Lower Costs
*
Senate F . . .
* * *
Wyden, Senate Democrats, Press Pharmaceutical Companies for Evidence of Cost Savings for Americans Following Secret Deals with Trump
Senate Democrats Continue Probe Into Trump's Sweetheart Deals for Big Pharma, Seeking Evidence That American Taxpayers Will Benefit from Lower Costs
*
Senate F . . .
